Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Research in Developmental Disabilities
|
April 23, 2025
Less antipsychotics, more Quality of Life tapering strategies for adults with intellectual disabilities and challenging behaviour
P Laermans, F Morisse, C Claes, et al.
Journal of Affective Disorders
|
April 23, 2003
Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide
C van Heeringen, K Audenaert, K Van Laere, et al.
European Journal of Nuclear Medicine
|
April 17, 2001
Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients
K Audenaert, K Van Laere, F Dumont, et al.
Nuclear Medicine Communications
|
March 22, 2001
The classical stroop interference task as a prefrontal activation probe: a validation study using 99Tcm-ECD brain SPECT
K Audenaert, P Lahorte, B Brans, et al.
International Journal of Developmental Disabilities
|
May 22, 2023
Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour
P Laermans, F Morisse, M Lombardi, et al.
Veterinary Journal (London, England : 1997)
|
April 23, 2018
Changes in canine cerebral perfusion after accelerated high frequency repetitive transcranial magnetic stimulation (HF-rTMS): A proof of concept study
R Dockx, C Baeken, R Duprat, et al.
Acta Psychiatrica Scandinavica
|
February 25, 2012
Parsing the components of the psychomotor syndrome in schizophrenia
L Docx, M Morrens, C Bervoets, et al.
Psychiatry Research
|
September 11, 1999
Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type
B A Pickut, R A Dierckx, A Dobbeleir, et al.
Nuclear Medicine and Biology
|
August 24, 2001
In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor
M Vandecapelle, F De Vos, H Vermeirsch, et al.
Nuclear Medicine Communications
|
July 19, 2003
Depression and anxiety during isolation and radionuclide therapy
B Brans, F van den Eynde, K Audenaert, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Research in Developmental Disabilities
|
April 23, 2025
Less antipsychotics, more Quality of Life tapering strategies for adults with intellectual disabilities and challenging behaviour
P Laermans, F Morisse, C Claes, et al.
Journal of Affective Disorders
|
April 23, 2003
Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide
C van Heeringen, K Audenaert, K Van Laere, et al.
European Journal of Nuclear Medicine
|
April 17, 2001
Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients
K Audenaert, K Van Laere, F Dumont, et al.
Nuclear Medicine Communications
|
March 22, 2001
The classical stroop interference task as a prefrontal activation probe: a validation study using 99Tcm-ECD brain SPECT
K Audenaert, P Lahorte, B Brans, et al.
International Journal of Developmental Disabilities
|
May 22, 2023
Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour
P Laermans, F Morisse, M Lombardi, et al.
Veterinary Journal (London, England : 1997)
|
April 23, 2018
Changes in canine cerebral perfusion after accelerated high frequency repetitive transcranial magnetic stimulation (HF-rTMS): A proof of concept study
R Dockx, C Baeken, R Duprat, et al.
Acta Psychiatrica Scandinavica
|
February 25, 2012
Parsing the components of the psychomotor syndrome in schizophrenia
L Docx, M Morrens, C Bervoets, et al.
Psychiatry Research
|
September 11, 1999
Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type
B A Pickut, R A Dierckx, A Dobbeleir, et al.
Nuclear Medicine and Biology
|
August 24, 2001
In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor
M Vandecapelle, F De Vos, H Vermeirsch, et al.
Nuclear Medicine Communications
|
July 19, 2003
Depression and anxiety during isolation and radionuclide therapy
B Brans, F van den Eynde, K Audenaert, et al.
Page
of 6